Suki, a healthcare startup revolutionizing how doctors handle administrative tasks, has raised $70 million in its Series D funding round. The company, founded by former Google and Flipkart executive Punit Soni, develops AI-powered voice assistants aimed at easing the burden of clinical documentation for healthcare providers. With its flagship products, Suki Assistant and Suki Platform, the startup is driving the adoption of AI in hospitals across the U.S., helping physicians focus more on patient care by reducing the administrative workload.
Suki’s latest funding round was led by tech investment firm Hedosophia, with additional backing from Venrock and March Capital, bringing the company’s total funding to $165 million. While Suki has not disclosed its exact valuation, sources familiar with the deal indicate it now sits at around $500 million. This financial boost will accelerate product development, with Suki planning to enhance its assistant with more features and introduce tools to manage multiple AI models.
Suki has capitalized on the growing interest in generative AI across healthcare, particularly since the rise of tools like OpenAI’s ChatGPT. “When the AI trend kicked in, every health system wanted to have an AI strategy,” Soni explained, pointing to the company’s proprietary tech stack, which has been evolving since its inception in 2017.
The startup’s technology is deeply integrated with major Electronic Health Record (EHR) systems, such as Epic, Oracle-owned Cerner, Athenahealth, and MEDITECH, making it one of the most widely adopted AI solutions in the healthcare sector. Suki’s voice assistants streamline clinical workflows, enabling physicians to quickly create and manage patient records through voice commands.
One of Suki’s standout innovations is its ambient Problem-Based Charting (PBC) feature. PBC organizes patient data around specific diagnoses, allowing clinicians to focus on the most critical aspects of a patient’s health. By combining deep EHR integrations with cutting-edge AI, Suki’s PBC has delivered significant improvements in clinical documentation. Since its launch, it has been adopted across over 50 medical specialties, including cardiology and orthopedic surgery. In August alone, it helped clinicians capture 118,000 additional problems, generated 65,000 plans for diagnoses, and created 68,000 notes with problem-based suggestions.
Suki’s competition includes Microsoft-owned Nuance, which has long dominated the market with its Dragon Medical One platform. However, Suki’s rapid growth and strong customer satisfaction – evidenced by its high Net Promoter Scores (NPS) – position it as a formidable competitor in the space. The company has tripled in size over the past few months and continues to secure new partnerships within the healthcare ecosystem.
As Suki accelerates its product development, the company is poised to expand its AI assistant’s capabilities to new areas of medicine, including tools for nurses. According to Soni, this ongoing expansion is about more than just keeping up with the hype; it’s about delivering a product that truly works for healthcare providers. “There’s a lot of noise in the market,” he said, “but the reality is in continuous deployments, strong user feedback, and a vision to bring joy back to medicine.”